Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v6-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2021-04-12 | 2021-04-12 |
| Drug Identification Number | 02202581 | 02202581 |
| Brand name | FEIBA NF | FEIBA NF |
| Common or Proper name | ANTI INHIBITOR COAGULANT COMPLEX | ANTI INHIBITOR COAGULANT COMPLEX |
| Company Name | TAKEDA CANADA INC | TAKEDA CANADA INC |
| Ingredients | ANTI-INHIBITOR COAGULANT COMPLEX | ANTI-INHIBITOR COAGULANT COMPLEX |
| Strength(s) | 1300UNIT | 1300UNIT |
| Dosage form(s) | POWDER FOR SOLUTION KIT | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20 mL | 20 mL |
| ATC code | B02BD | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2021-03-02 | 2021-03-02 |
| Actual start date | ||
| Estimated end date | 2021-04-16 | 2021-04-16 |
| Actual end date | 2021-03-30 | 2021-03-30 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | Planned shortage to begin March 02, 2021 | Planned shortage to begin March 02, 2021 |
| Health Canada comments |